Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luboš Remeň

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Chemmedchem|February 23, 2025
Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of CancerStefan Diethelm, Luboš Remeň, Hamed Aissaoui, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2017
Discovery and evaluation of Ca<sub>v</sub>3.2-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2017
Discovery and evaluation of Ca<sub>v</sub>3.1-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Piperidine-based renin inhibitors: upper chain optimizationOlivier Corminboeuf, Olivier Bezençon, Luboš Remeň, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Design and optimization of new piperidines as renin inhibitorsOlivier Corminboeuf, Olivier Bezençon, Corinna Grisostomi, et al.
Chimia|October 27, 2017
Milestones to the Discovery of T-type Calcium Channel Blockers for the Treatment of Generalized EpilepsiesOlivier Bezençon, Romain Siegrist, Bibia Heidmann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Chemmedchem|February 23, 2025
Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of CancerStefan Diethelm, Luboš Remeň, Hamed Aissaoui, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2017
Discovery and evaluation of Ca<sub>v</sub>3.2-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2017
Discovery and evaluation of Ca<sub>v</sub>3.1-selective T-type calcium channel blockersOlivier Bezençon, Luboš Remeň, Sylvia Richard, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Piperidine-based renin inhibitors: upper chain optimizationOlivier Corminboeuf, Olivier Bezençon, Luboš Remeň, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Design and optimization of new piperidines as renin inhibitorsOlivier Corminboeuf, Olivier Bezençon, Corinna Grisostomi, et al.
Chimia|October 27, 2017
Milestones to the Discovery of T-type Calcium Channel Blockers for the Treatment of Generalized EpilepsiesOlivier Bezençon, Romain Siegrist, Bibia Heidmann, et al.
Pageof 1